Alewine, G.; Knight, J.; Ghantae, A.; Mamrega, C.; Attiah, B.; Coover, R.A.; Fahrenholtz, C.D.
Silver Nanoparticles Selectively Treat Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors in a Neurofibromin-Dependent Manner. J. Pers. Med. 2022, 12, 1080.
https://doi.org/10.3390/jpm12071080
AMA Style
Alewine G, Knight J, Ghantae A, Mamrega C, Attiah B, Coover RA, Fahrenholtz CD.
Silver Nanoparticles Selectively Treat Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors in a Neurofibromin-Dependent Manner. Journal of Personalized Medicine. 2022; 12(7):1080.
https://doi.org/10.3390/jpm12071080
Chicago/Turabian Style
Alewine, Garrett, Jerrica Knight, Adithya Ghantae, Christina Mamrega, Bashnona Attiah, Robert A. Coover, and Cale D. Fahrenholtz.
2022. "Silver Nanoparticles Selectively Treat Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors in a Neurofibromin-Dependent Manner" Journal of Personalized Medicine 12, no. 7: 1080.
https://doi.org/10.3390/jpm12071080
APA Style
Alewine, G., Knight, J., Ghantae, A., Mamrega, C., Attiah, B., Coover, R. A., & Fahrenholtz, C. D.
(2022). Silver Nanoparticles Selectively Treat Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors in a Neurofibromin-Dependent Manner. Journal of Personalized Medicine, 12(7), 1080.
https://doi.org/10.3390/jpm12071080
